Company
Summary
Fields
Makes robotic systems for Aquablation therapy, a waterjet treatment for benign prostatic hyperplasia (BPH).
| Investor | Rounds |
|---|---|
| Physicians Management Group Series D, Series E, Series G | Series D, Series E, Series G |
| Viking Global Investors Series ELead, Series G | Series ELead, Series G |
| Perceptive Advisors Series E, Series G | Series E, Series G |
| Novo Capital Series DLead | Series DLead |
| Novo Holdings Series DLead | Series DLead |
| Armentum Partners Debt Refin. | Debt Refin. |
| Fidelity Investments Series GLead | Series GLead |
| T. Rowe Price Series G | Series G |
| Duquesne Family Office LLC Series G | Series G |
| CIBC Innovation Banking Debt - PPPLead | Debt - PPPLead |
Aviato · checked 12 Oct 2026
Medical and surgical
Robotic system used in Aquablation therapy, a waterjet treatment for BPH.
Commercial
Not stated
Evidence
Company demo only
Medical and surgical
AI-powered robotic platform for Aquablation therapy, a waterjet treatment for BPH.
Commercial
Not stated
Evidence
Company demo only
FDA 510(k) clearance K260723: HYDROS Robotic System (HY1000);HYDROS Handpiece (HH1000);HYDROS TRUS Probe (HU1000)
FDA 510(k) clearance K253211: AQUABEAM Robotic System
FDA 510(k) clearance K251082: HYDROS Robotic System (HY1000); HYDROS Handpiece (HH1000); HYDROS TRUS Probe (HU1000)
FDA 510(k) clearance K241952: AQUABEAM Robotic System (AB2000)
FDA 510(k) clearance K240200: HYDROS Robotic System; HYDROS TRUS Probe; HYDROS Handpiece
PROCEPT BioRobotics names HYDROS Robotic System on its website.
PROCEPT BioRobotics names AquaBeam Robotic System on its website.
PROCEPT BioRobotics
2 machines on robomap
FDA De Novo grant DEN170024: AQUABEAM System